Navigation Links
Gates Foundation Commits $280 Million for Research to Fight Global TB Epidemic
Date:9/18/2007

B drug discovery grants announced today include:

-- $7.5 million to Seattle Biomedical Research Institute

-- Two grants totaling $3.7 million to Colorado State University

-- Two grants totaling $2.4 million to Weill Cornell Medical College

-- $1.8 million to Johns Hopkins University

-- $1.7 million to Ordway Research Institute

-- $750,000 to Northeastern University

-- $453,000 to Ecole Polytechnique Federale de Lausanne

Grants Support Global Plan to Stop TB

The new grants support priorities in the Stop TB Partnership's Global Plan to Stop TB, a detailed blueprint for reducing the TB burden over the next decade. The plan calls for worldwide spending on TB to triple by 2015.

Last year, the foundation pledged to support the plan by providing at least $900 million in TB funding by 2015. With the new grants announced today, the foundation has fulfilled more than half of that commitment.

"TB is a major threat, and stopping it must be a top global priority," said Dr. Marcos Espinal, executive secretary of the Stop TB Partnership. "We have an achievable action plan to reduce the TB burden, and it is encouraging to see new resources going to Stop TB partners to support this plan."

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people's health, and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people, especially those with the fewest resources, have access to the opportunities they need to succeed in school and life. Based in Seattle, the foundation is led by CEO Patty Stonesifer and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.


'/>"/>
SOURCE The Bill & Melinda Gates Foundation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bill Gates to Fund ?28m for Malaria researc
2. Bill Gates Takes Personal Interest in AIDS Program
3. Dr.Tadataka Yamada Designated to open Gates for Global Health Program
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Gates Foundation to donate USD 104 million to TB Alliance
6. Division Among Delegates To Dilute UNs AIDS Plans: Activists
7. Bill Gates Clarifies that his Decision to Focus on Charity was Personal
8. Gates Foundation Adopts Fight against Encephalitis
9. Clinton, Gates Highlight Treatment, Discrimination of AIDS
10. A Synthetic Molecule Instigates Cancer Cells To Self-Harm
11. $68 million aid pours in from Gates Foundation to fight tropical diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:ATS Medical Appoints James L. Cox, M.D. as Medical Director 2Health News:ATS Medical Appoints James L. Cox, M.D. as Medical Director 3Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on the Release of the 2007 Monitoring the Future Study 2Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on the Release of the 2007 Monitoring the Future Study 3Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on the Release of the 2007 Monitoring the Future Study 4Health News:Blue Cross of California Gives $30,000 in Holiday Donations to Food Banks Throughout the State 2Health News:Panacea Pharmaceuticals Initiates GMP Manufacturing of Prostate Cancer Diagnostic Test Kits 2Health News:Panacea Pharmaceuticals Initiates GMP Manufacturing of Prostate Cancer Diagnostic Test Kits 3Health News:Panacea Pharmaceuticals Initiates GMP Manufacturing of Prostate Cancer Diagnostic Test Kits 4Health News:Rand study examines the effect of policy on entrepreneurship and small businesses 2Health News:Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee 2Health News:Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee 3Health News:Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee 4
Breaking Medicine Technology:ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 3Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 1ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 2ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 3ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 4Mount Sinai leads unprecedented NIH supported attempt to discover rules for assembling human tissue 58221 1Mount Sinai leads unprecedented NIH supported attempt to discover rules for assembling human tissue 58221 2Mount Sinai leads unprecedented NIH supported attempt to discover rules for assembling human tissue 58221 3Groundbreaking model of heart disease rewarded with NIH Pioneer Award 10079 1Groundbreaking model of heart disease rewarded with NIH Pioneer Award 10079 2Groundbreaking model of heart disease rewarded with NIH Pioneer Award 10079 3